These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 6214916
21. First dose effect of the oral angiotensin converting enzyme inhibitor captopril. Fagard R, Amery A, Lijnen P, Staessen J. Arch Int Pharmacodyn Ther; 1980; Suppl():178-87. PubMed ID: 6251761 [Abstract] [Full Text] [Related]
22. Acute effect of captopril on serum lipid peroxides level in hypertensive patients. Mizuno K, Gotoh M, Fukuchi S. Tohoku J Exp Med; 1984 May; 143(1):127-8. PubMed ID: 6379987 [Abstract] [Full Text] [Related]
23. [Use of captopril in cardiology practice]. Zhukova IM. Kardiologiia; 1983 Apr; 23(4):110-4. PubMed ID: 6345885 [No Abstract] [Full Text] [Related]
24. [Effect of captopril on renin-aldosterone system in essential hypertension]. Yu ZY. Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):84-5. PubMed ID: 3058446 [No Abstract] [Full Text] [Related]
26. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition. Bauer JH. Am J Med; 1984 Aug 20; 77(2A):43-51. PubMed ID: 6206722 [Abstract] [Full Text] [Related]
30. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension. Sassano P, Pedrinelli R, Magagna A, Abdel-Haq B, Salvetti A. Am J Cardiol; 1982 Apr 21; 49(6):1574-6. PubMed ID: 6280486 [Abstract] [Full Text] [Related]
31. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Romankiewicz JA, Brogden RN, Heel RC, Speight TM, Avery GS. Drugs; 1983 Jan 21; 25(1):6-40. PubMed ID: 6218982 [Abstract] [Full Text] [Related]
32. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II]. Schalekamp MA, de Bruyn JH, Wenting GJ, Man in 't Veld AJ, Derkx FH. Ned Tijdschr Geneeskd; 1980 Nov 22; 124(47):1996-2003. PubMed ID: 6255350 [No Abstract] [Full Text] [Related]
33. [Use of captopril in circulatory failure]. Mareev VIu. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982 Nov 22; 5(2):109-14. PubMed ID: 6753872 [No Abstract] [Full Text] [Related]
36. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients. Ogihara T, Maruyama A, Hata T, Mikami H, Nakamaru M, Naka T, Ohde H, Kumahara Y. Clin Pharmacol Ther; 1981 Sep 22; 30(3):328-35. PubMed ID: 6268347 [Abstract] [Full Text] [Related]
37. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI. Br Heart J; 1980 Sep 22; 44(3):290-6. PubMed ID: 7000102 [Abstract] [Full Text] [Related]